Short answer · Medically reviewed summary · Last updated: 2026-05-08
Familial Partial Lipodystrophy is primarily classified under the ICD-10 code E88.1 (Lipodystrophy, not elsewhere classified), while in the older ICD-9 system, it was categorized under 272.8 (Other disorders of lipoid metabolism). These codes are essential for medical billing and tracking the clinical progression of Familial Partial Lipodystrophy in healthcare databases. What is the clinical significance of these codes for Familial Partial Lipodystrophy? Because Familial Partial Lipodystrophy is a rare genetic disorder, accurate coding is vital for ensuring patients receive appropriate metabolic monitoring.
ICD10 code of Familial Partial Lipodystrophy and ICD9 code
ICD-10 and ICD-9 codes for Familial Partial Lipodystrophy, with classification details for clinicians, coders and patients.
Familial Partial Lipodystrophy is primarily classified under the ICD-10 code E88.1 (Lipodystrophy, not elsewhere classified), while in the older ICD-9 system, it was categorized under 272.8 (Other disorders of lipoid metabolism). These codes are essential for medical billing and tracking the clinical progression of Familial Partial Lipodystrophy in healthcare databases.
What is the clinical significance of these codes for Familial Partial Lipodystrophy?
Because Familial Partial Lipodystrophy is a rare genetic disorder, accurate coding is vital for ensuring patients receive appropriate metabolic monitoring. The ICD-10 code E88.1 captures the systemic nature of the condition, which often involves insulin resistance, diabetes, and dyslipidemia. Using the correct diagnostic code helps specialists track the long-term management of Familial Partial Lipodystrophy and facilitates access to specialized metabolic care.
How does Familial Partial Lipodystrophy present?
Patients with Familial Partial Lipodystrophy typically experience a progressive loss of subcutaneous fat from the extremities, trunk, and hips, often starting during puberty. This is frequently accompanied by an accumulation of fat in the face, neck, and abdominal regions. Our DiseaseMaps community, which includes 27 members living with Familial Partial Lipodystrophy, often discusses the challenges of managing the associated metabolic complications that arise from this altered fat distribution.
What diagnostic markers should be monitored?
Clinical management of Familial Partial Lipodystrophy requires regular screening for the following metabolic indicators:
- Fasting glucose and HbA1c levels to monitor for insulin resistance or diabetes.
- Comprehensive lipid profiles, as patients often exhibit hypertriglyceridemia.
- Liver function tests due to the high risk of non-alcoholic fatty liver disease (NAFLD).
- Blood pressure monitoring to manage cardiovascular risks.
Next steps
- Consult an endocrinologist with specific expertise in lipid disorders.
- Connect with the 27 members of the Familial Partial Lipodystrophy community on DiseaseMaps.org to share experiences and coping strategies.
- Request genetic testing to identify specific mutations, such as those in the LMNA or PPARG genes, which often confirm the diagnosis.
Medical disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Familial partial lipodystrophy.
- Orphanet: Familial partial lipodystrophy (ORPHA:538).
- Online Mendelian Inheritance in Man (OMIM): #151660 (Familial Partial Lipodystrophy, Dunnigan Type).
- International Classification of Diseases, 10th Revision (ICD-10) Browser.
